6533b870fe1ef96bd12d0798
RESEARCH PRODUCT
Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood
José Luis PiñanaS ZaragozaS PoujoisMarisa CalabuigVíctor VinuesaCarlos SolanoDavid NavarroEugenio Gimenezsubject
AdultMale0301 basic medicineAdolescent030106 microbiologyCytomegalovirusVirus ReplicationAntiviral AgentsYoung Adult03 medical and health sciences0302 clinical medicineHumansTransplantation HomologousMedicineDoubling timeProgenitor cellGanciclovirAgedTransplantationbusiness.industryHematopoietic Stem Cell TransplantationAntiviral therapyHematologyMiddle Agedmedicine.diseaseTransplantationGraft-versus-host diseaseCytomegalovirus InfectionsDNA ViralImmunologyFemaleStem cellbusiness030215 immunologydescription
Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood
year | journal | country | edition | language |
---|---|---|---|---|
2015-12-07 | Bone Marrow Transplantation |